Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

被引:2408
作者
Nathan, David M. [1 ]
Buse, John B. [8 ]
Davidson, Mayer B. [7 ]
Ferrannini, Ele [6 ]
Holman, Rury R. [5 ]
Sherwin, Robert [3 ,4 ]
Zinman, Bernard [2 ]
机构
[1] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA
[2] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Yale Ctr Clin Invest, New Haven, CT 06510 USA
[5] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England
[6] Univ Pisa, Dept Internal Med, Pisa, Italy
[7] Charles R Drew Univ Med & Sci, Clin Ctr Res Excellence, Los Angeles, CA 90059 USA
[8] Univ N Carolina, Sch Med, Chapel Hill, NC USA
关键词
DIPEPTIDYL PEPTIDASE-4 INHIBITOR; INTENSIVE INSULIN THERAPY; IMPROVED GLYCEMIC CONTROL; MICROVASCULAR COMPLICATIONS; CARDIOVASCULAR EVENTS; COMBINATION THERAPY; EXENATIDE EXENDIN-4; BLOOD-GLUCOSE; DRUG-THERAPY; METFORMIN;
D O I
10.2337/dc08-9025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues Surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience.
引用
收藏
页码:193 / 203
页数:11
相关论文
共 92 条
[1]  
ABRAIRA C, 2008, DIABETES OBES M 0729
[2]   PROBABILITY FORECASTING [J].
ABRAMSON, B ;
CLEMEN, R .
INTERNATIONAL JOURNAL OF FORECASTING, 1995, 11 (01) :1-4
[3]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[4]   Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis [J].
Amori, Renee E. ;
Lau, Joseph ;
Pittas, Anastassios G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02) :194-206
[5]  
[Anonymous], 1999, Diabet Med, V16, P716
[6]  
[Anonymous], 1995, Diabetes, V44, P1249
[7]  
[Anonymous], 1995, DIABETES, V44, P968
[8]  
[Anonymous], 2008, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD006739
[9]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[10]   Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus [J].
Bolen, Shari ;
Feldman, Leonard ;
Vassy, Jason ;
Wilson, Lisa ;
Yeh, Hsin-Chieh ;
Marinopoulos, Spyriclon ;
Wiley, Crystal ;
Selvin, Elizabeth ;
Wilson, Renee ;
Bass, Eric B. ;
Brancati, Frederick L. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) :386-399